Metabolic disorders: all that we know from circulating biomarkers
SSEA4: a marker leading the way towards curing diabetes?
Circulating biomarkers for metabolic disorders as a predictor of cardiovascular disease risk: what's new?
Metabolic syndrome in youth: current insights and novel serum biomarkers
Circulating miRNA profiling to identify biomarkers of dysmetabolism
Serum biomarkers in nonalcoholic steatohepatitis: value for assessing drug effects?
Human serum proteome analysis: new source of markers in metabolic disorders
8-OHdG: its (limited) potential as a biomarker for Huntington's disease
Investigators have identified potential protein biomarkers to help diagnose mesothelioma
Study reveals 14 potential metabolite biomarkers for Type 2 diabetes
A chemical that detects protein citrullination may help identify novel biomarkers for certain human diseases
Research suggests a link between neurotensin and several diseases in women
Researchers identify the potential molecular mechanism behind sporadic Parkinson's disease
Research Highlights: Ultrasensitive cardiac troponin and myocardial strain predict cardiotoxicity
Marker of kidney injury predicts outcome after angioplasty for acute myocardial infarction
Novel multimarker score predicts outcome in heart failure
Marker to predict neurological outcome after out-of-hospital cardiac arrest
Equal performance of novel N-terminal proBNP (Cardiac proBNP®) and established BNP (Triage BNP®) point-of-care tests
Association between polymorphisms of glutathione S -transferase genes ( GSTM1, GSTP1 and GSTT1 ) and breast cancer risk in a sample Iranian population
Increased levels of soluble ICAM-1 in chronic obstructive pulmonary disease and resistant smokers are related to active smoking
The role of iron overload on oxidative stress in sickle cell anemia
Correlation between cord blood apelin and IGF-1 levels in retinopathy of prematurity
The natriuretic peptides as biomarkers for adults with congenital heart disease
US FDA draft Guidance Standard for Clinical Trial Imaging Endpoints: more than just imaging?
An omics strategy for discovering pulmonary biomarkers potentially relevant to the evaluation of tobacco products